Phoseon Technology builds world's largest UVC LED disinfection system
Designed to inactivate RNase A in Covid-19 RT-PCR test kits
Designed to inactivate RNase A in Covid-19 RT-PCR test kits
Learn about the large scale COVID-19 PCR testing program set up by the government of Luxembourg
Explore topics from Alzheimer's disease and mRNA vaccine production to SARS-CoV-2 detection in wastewater and nanoplastic characterization
This cutting-edge technology has the potential to vastly improve care, offering accessible and affordable brain imaging that can take place at the patient’s bedside
The first-of-its-kind steerable delivery system is designed to seal the left atrial appendage in people who are at increased risk of stroke due to atrial fibrillation
Integration expands automated, ultra-low volume dispensing capabilities across point-of-care diagnostics, clinical diagnostics and the life sciences, positioning customers for further growth
Guest editorial: Learn how clinicians can utilize diagnostic information to make decisions when examining suspected SARS-CoV-2 patients
From its expedited development to its far-reaching adoption, COVID-19 antigen testing is helping students and workforces safely return to daily life
Watch world-leading clinical scientists and healthcare professionals online, June 22-23, to discover the latest tools and techniques advancing COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
Access to mechanical circulatory support devices is critical for advanced heart failure patients and can improve survival, clinical outcomes and quality of life
The catheter transforms care delivery by enabling access to structural heart procedures for patients with tricuspid regurgitation and other pathologies
Explore cutting-edge technologies and the latest resources to support your materials characterization
Dr. Marco Caffio reveals how his team took on a seemingly impossible mission – to produce pristine, scalable, and reproducible graphene at a low cost
Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk of disease recurrence or death by 80%
The fast time-to-result includes a pretreatment process to inactivate the virus as a safeguard for laboratory staff handling the samples
Explore the latest science and technology advancements in regenerative medicine, COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more
Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences
Explore topics from live-cell analysis, in situ hybridization, cancer therapeutics, cell imaging, and much more
Genome editing experts harness the power of CRISPR-Cas enzymes to power the next diagnostic revolution in COVID-19 detection and diagnosis
For a chance to win a $500/£400/450€ Amazon Gift Card, cast your vote for the new products which have made the most difference to clinical diagnostics
Discover how to increase precision and reduce throughput time of your routine electrolyte analyses